Thrivent Financial for Lutherans
NUVB icon

Thrivent Financial for Lutherans’s Nuvation Bio NUVB Stock Holding History

Thrivent Financial for Lutherans’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-111,964
Closed -$327K – 2568
2024
Q2 		$327K Sell
111,964
-4,784
-4% -$14.6K ﹤0.01% 2365
2024
Q1 		$425K Hold
116,748
– – ﹤0.01% 2283
2023
Q4 		$176K Buy
+116,748
New +$150K ﹤0.01% 2442

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Thrivent Financial for Lutherans's NUVB Position: Q3 2024 in Review

Thrivent Financial for Lutherans sold out of Nuvation Bio (NUVB) in Q3 2024, closing a stake of 111,964 shares — an estimated $327K sold.

Thrivent Financial for Lutherans first reported a position in NUVB in Q4 2023 and held it in 3 quarters. The position peaked at $425K in Q1 2024. 154 funds tracked by Wall St. Rank hold NUVB as of Q3 2024.

  • Thrivent Financial for Lutherans reported no remaining Nuvation Bio position as of Q3 2024 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 111,964 Nuvation Bio shares in Q3 2024, an estimated $327K.
  • Thrivent Financial for Lutherans first reported a position in Nuvation Bio in Q4 2023 and held it in 3 quarters.
  • Thrivent Financial for Lutherans's Nuvation Bio position peaked at $425K in Q1 2024.
  • 154 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2024.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2024, filed 7 Nov 2024.